Lilly says Mounjaro and Zepbound sales more than doubled as stock rallies
Late last year, Lilly was the first pharmaceutical stock to reach a $1 trillion valuation. View Source Jaimy Lee MarketWatch.com – Top Stories February 4,…
Statuses
First Traditional Retailer To Join $1T Club
View Source Most popular articles February 4, 2026 5:30 am
Where should I retire? How to use all those ‘best places’ lists to find your perfect spot.
Here’s a rundown of six best-places lists in the U.S. and two global ones. View Source Richard Eisenberg MarketWatch.com – Top Stories February 4, 2026…
Energy, Infrastructure, And Industrials – My Favorite Places To Invest For The Next Decade
View Source Most popular articles February 4, 2026 5:30 am
Investors were braced for an AI fallout — just not this one, popular strategist says.
Nomura’s Charlie McElligott says second-order AI disruption worries have arrived early. Investors need to get ready. View Source Barbara Kollmeyer MarketWatch.com – Top Stories February…
Lilly says Mounjaro and Zepbound sales grew by at least 110% as stock rallies
The drugmaker also detailed strong growth for 2026 View Source Jaimy Lee MarketWatch.com – Top Stories February 4, 2026 5:21 am
‘I’m spooked’: Gold is back above $5,000, but is it a high-risk bet for your retirement?
“Before you ask, there is nothing extreme about 5% of my ‘alternative’ assets.” View Source Quentin Fottrell MarketWatch.com – Top Stories February 4, 2026 5:00…
Gold’s back over $5,000 and silver’s surging as well
Gold futures reclaimed the $5,000 level on Wednesday, as the yellow metal was back on vogue after suffering through the worst performance in 46 years…
Novo Nordisk CEO tells investors to expect weight-loss drug pricing to go down before it comes back up
Recently-appointed CEO Mike Doustdar has repeatedly reset expectations since his arrival. Pricing and regulatory pressure is fierce and pessimistic revenue guidance has seen the stock…
Santander says $12 billion U.S. bank deal will cost less than 7 times earnings. The market isn’t buying it.
Santander shares fell on Wednesday, as Spanish investors reacted to the banking giant’s latest $12 billion acquisition. View Source Steve Goldstein MarketWatch.com – Top Stories…